ALEXANDRA/Impassion030
ALEXANDRA/IMpassion030: Phase III Trial of Adjuvant Chemotherapy ± Atezolizumab for Stage II/III Triple-Negative Breast Cancer

Released: December 08, 2023

Activity

Progress
1
Course Completed